Latvia vs Syria: Incidence of tuberculosis (per 100,000 people)
Incidence of tuberculosis (per 100,000 people) over time
- Latvia
- Syria
How they compare
Syria currently reports 23 per 100,000 people against 21 per 100,000 people in Latvia, a difference of 2 per 100,000 people.
That makes Syria's figure about 1.1 times Latvia's.
The two have swapped places 1 time across 25 shared years of data; in 2000 it was Latvia ahead.
Latvia ranks 126th and Syria ranks 124th of 208 countries.
Across the 3 decades both report, Latvia averaged higher in 2 and Syria in 1.
Head to head by decade
| Decade | Latvia | Syria | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 135.9 per 100,000 people | 53.6 per 100,000 people | 82.3 per 100,000 people | Latvia |
| 2010s | 54.2 per 100,000 people | 25.7 per 100,000 people | 28.5 per 100,000 people | Latvia |
| 2020s | 21.4 per 100,000 people | 22.4 per 100,000 people | 1 per 100,000 people | Syria |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher incidence of tuberculosis, Latvia or Syria?
- Syria, at 23 per 100,000 people against 21 per 100,000 people in Latvia as of 2024.
- What is the difference in incidence of tuberculosis between Latvia and Syria?
- 2 per 100,000 people, with Syria ahead.
- How many years of comparable data are there for Latvia and Syria?
- 25 years are reported by both, from 2000 to 2024.
- How do Latvia and Syria rank globally for incidence of tuberculosis?
- Latvia ranks 126th and Syria ranks 124th of 208 countries.
- Where does this data come from?
- Global Tuberculosis Report, World Health Organization (WHO), published as Incidence of tuberculosis (per 100,000 people). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Incidence of tuberculosis is the estimated number of new and relapse tuberculosis cases arising in a given year, expressed as the rate per 100,000 population. All forms of TB are included, including cases in people living with HIV. Estimates for all years are recalculated as new information becomes available and techniques are refined, so they may differ from those published previously.